<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To evaluate corneal advanced glycation end product (AGE) fluorescence in patients with <z:mp ids='MP_0002055'>diabetes</z:mp> and in healthy control subjects </plain></SENT>
<SENT sid="1" pm="."><plain>RESEARCH DESIGN AND METHODS: Corneal autofluorescence was measured in 26 eyes of 26 patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> (mean age 57.0 years; mean disease duration 12.2 years; mean HbA1c 7.1%) and 13 eyes of 13 healthy age-matched control subjects (mean age 57.9 years) </plain></SENT>
<SENT sid="2" pm="."><plain>The patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> were divided into the following groups: patients without diabetic <z:hpo ids='HP_0000488'>retinopathy</z:hpo> (DR), patients without proliferative diabetic <z:hpo ids='HP_0000488'>retinopathy</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PDR</z:e>), and patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PDR</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>Corneal autofluorescence was measured by fluorophotometry with the wavelength that is characteristic of AGE fluorescence (excitation and emission 360-370 nm and 430-450 nm, respectively) </plain></SENT>
<SENT sid="4" pm="."><plain>We defined peak corneal autofluorescence levels as corneal AGE fluorescence values </plain></SENT>
<SENT sid="5" pm="."><plain>We compared the corneal AGE fluorescence values in the four groups </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: In the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PDR</z:e> group (11.9 +/- 3.9 arbitrary units [mean +/- SD]), the corneal AGE fluorescence values were significantly higher compared with the control subjects (6.9 +/- 1.3 arbitrary units), the patients without DR (7.4 +/- 2.1 arbitrary units), and the patients without <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PDR</z:e> (6.9 +/- 2.2 arbitrary units) (P &lt; 0.05) </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSIONS: We found that corneal AGEs may increase in patients with <z:mp ids='MP_0002055'>diabetes</z:mp> and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PDR</z:e> compared with control subjects, patients without DR, and patients without <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PDR</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>In the patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PDR</z:e>, increased corneal AGEs may play a role in diabetic <z:e sem="disease" ids="C0235270" disease_type="Disease or Syndrome" abbrv="">keratopathy</z:e> </plain></SENT>
</text></document>